Experiments evaluating the effect of SX-682, palbociclib, or the combination of inhibitors were also conducted in C57Bl/6 mice bearing 1014 NRAS mutant (NRASmut) melanoma xenografts over a treatment period of two weeks. The gene discussed is NRAS; the disease is melanoma.